Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email
Brian Ko

Brian Ko, M.D.

  • Medical Officer
  • NCI Division of Cancer Treatment and Diagnosis (DCTD) Cancer Therapy Evaluation Program (CTEP)
  • Investigational Drug Branch
240-276-6565 |
Scientific Publications

Dr. Brian Ko joined the Investigational Drug Branch (IDB) at the National Cancer Institute (NCI) in 2024. He earned his undergraduate degree from Harvard University and his M.D. from the University of Illinois. He completed his internal medicine residency and medical oncology/hematology fellowship at Montefiore Einstein. He then undertook further subspeciality training in early phase cancer clinical trials and oncologic drug development at the Advanced Developmental Therapeutics Training Program at NCI.

  • Updated:
Email